VISCHER advised Oberland Capital in this transaction. Oberland Capital Management LLC signed a financing agreement with the Helsinn Group. Oberland Capital is a private investment firm...
Helsinn’s Financing Agreement with Oberland Capital
E3 Holding AG’s Acquisition of Clean-tek Gruppe
VISCHER acted as lead counsel to the buyer. Heuking Kühn Lüer Wojtek advised NORD/LB Norddeutsche Landesbank – Girozentrale. E3 Holding AG, Germany, has acquired the clean-tek...
Hangzhou GreatStar Industrial Co., Ltd.’s Listing on the SIX Swiss Exchange
Clifford Chance, Niederer Kraft Frey, Vischer and T&C Law Firm advised Hangzhou GreatStar Industrial Co., Ltd. on the deal. Allen & Overy advised the sole global...
Lunaphore Technologies’ €10 Million Debt Financing
Vischer advised Norgine Ventures on the deal. Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.The financing was realised in form of...
Ningbo Shanshan’s $310.5 Million GDRs Issuance and Listing on The SIX Swiss Exchange
Vischer, Advestra and Grandway advised Ningbo Shanshan on the deal. Niederer Kraft Frey has advised the underwriters led by Huatai Financial Holdings (Hong Kong) Limited and...
Afinum Management GmbH’s CHF 105 Million Acquisition of GS Swiss PCB
VISCHER advised the buyer on this transaction. Bär & Karrer acts as legal advisor to exceet Group in this transaction. A fund advised by AFINUM Management...
Atlas Antibodies’ Acquisition of Evitria Group
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...
Relief Therapeutics’ CHF 15 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright LLC on the deal, while VISCHER advised Relief Therapeutics. RELIEF THERAPEUTICS Holding AG. a biopharmaceutical company seeking to provide patients therapeutic relief from...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Relief Therapeutics’ Acquisition of Applied Pharma Research S.A.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
Loomis’ Acquisition of SecurePost AG
VISCHER advised Loomis. Loomis, a Sweden-based and listed provider of cash handling services for banks, retailers and other commercial clients, has, through its wholly owned subsidiary...
Relief Therapeutics Holding AG’s CHF 10 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright LLC, as sole placement agent for the offering, while VISCHER advised Relief regarding the Swiss legal aspects of this transaction. RELIEF THERAPEUTICS...